Serotype 5 pneumococci causing invasive pneumococcal disease outbreaks in barcelona, spain (1997 to 2011)

Journal of Clinical Microbiology

Volumn 51, Issue 11, 2013, Pages 3585-3590

  Rolo, Dora ^a,b   Fenoll, Asunción ^b   Fontanals, Dionísia ^c   Larrosa, Nieves ^d   Giménez, Montserrat ^b,e   Grau, Immaculada ^b   Pallarés, Román ^b   Liñares, Josefina ^a,b   Ardanuy, Carmen ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UDIAT Diagnostic Centre   (Spain)

^d HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^e HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CEFOTAXIME; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; ERYTHROMYCIN; PENICILLIN DERIVATIVE; TETRACYCLINE;

ADULT; AGE DISTRIBUTION; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CARDIOVASCULAR DISEASE; CHILD; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLONE; COMORBIDITY; CONTROLLED STUDY; EPIDEMIC; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR EPIDEMIOLOGY; MORTALITY; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PNEUMOCOCCAL INFECTION; PRESCHOOL CHILD; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SEROTYPE; SPAIN; STREPTOCOCCUS PNEUMONIAE; TEACHING HOSPITAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CARDIOVASCULAR DISEASES; CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; FEMALE; HOSPITALS, TEACHING; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; PNEUMOCOCCAL INFECTIONS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEROTYPING; SPAIN; STREPTOCOCCUS PNEUMONIAE; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84886558388     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01538-13     Document Type: Article

References (31)

1. Brueggemann AB, Peto TE, Crook DW, Butler JC, Kristinsson KG, Spratt BG. 2004. Temporal and geographic stability of the serogroupspecific invasive disease potential of Streptococcus pneumoniae in children. J. Infect. Dis. 190:1203-1211.
2. Sá-Leão R, Pinto F, Aguiar S, Nunes S, Carriço JA, Frazão N, Gonçalves- Sousa N, Melo-Cristino J, de Lencastre H, Ramirez M. 2011. Analysis of invasiveness of pneumococcal serotypes and clones circulating in Portugal before widespread use of conjugate vaccines reveals heterogeneous behavior of clones expressing the same serotype. J. Clin. Microbiol. 49:1369-1375.
3. Hausdorff WP. 2007. The roles of pneumococcal serotypes 1 and 5 in paediatric invasive disease. Vaccine 25:2406-2412.
4. Leimkugel J, Adams Forgor A, Gagneux S, Pflüger V, Flierl C, Awine E, Naegeli M, Dangy JP, Smith T, Hodgson A, Pluschke G. 2005. An outbreak of serotype 1 Streptococcus pneumoniae meningitis in northern Ghana with features that are characteristic of Neisseria meningitidis meningitis epidemics. J. Infect. Dis. 192:192-199.
5. Mercat A, Nguyen J, Dautzenberg B. 1991. An outbreak of pneumococcal pneumonia in two men's shelters. Chest 99:147-151.
6. Dagan R, Gradstein S, Belmaker I, Porat N, Siton Y, Weber G, Janco J, Yagupsky P. 2000. An outbreak of Streptococcus pneumoniae serotype 1 in a closed community in southern Israel. Clin. Infect. Dis. 30:319-321.
7. Gratten M, Morey F, Dixon J, Manning K, Torzillo P, Matters R, Erlich J, Hanna J, Asche V, Riley I. 1993. An outbreak of serotype 1 Streptococcus pneumoniae infection in central Australia. Med. J. Aust. 158:340-342.
8. Birtles A, McCarthy N, Sheppard CL, Rutter H, Guiver M, Haworth E, George RC. 2005. Multilocus sequence typing directly on DNA from clinical samples and a cultured isolate to investigate linked fatal pneumococcal disease in residents of a shelter for homeless men. J. Clin. Microbiol. 43:2004-2008.
9. Vanderkooi OG, Church DL, MacDonald J, Zucol F, Kellner JD. 2011. Community-based outbreaks in vulnerable populations of invasive infections caused by Streptococcus pneumoniae serotypes 5 and 8 in Calgary, Canada. PLoS One 6:e28547. doi:10.1371/journal.pone.0028547.
10. Sanz JC, Cercenado E, MarÍn M, Ramos B, Ardanuy C, RodrÍguez-Avial I, Bouza E. 2011. Multidrug-resistant pneumococci (serotype 8) causing invasive disease in HIV patients. Clin. Microbiol. Infect. 17:1094-1098.
11. Balicer RD, Zarka S, Levine H, Klement E, Sela T, Porat N, Ash N, Dagan R. 2010. Control of Streptococcus pneumoniae serotype 5 epidemic of severe pneumonia among young army recruits by mass antibiotic treatment and vaccination. Vaccine 28:5591-5596.
12. Pichon B, Moyce L, Sheppard C, Slack M, Turbitt D, Pebody R, Spencer DA, Edwards J, Krahé D, George R. 2010. Molecular typing of pneumococci for investigation of linked cases of invasive pneumococcal disease. J. Clin. Microbiol. 48:1926-1928.
13. Romney MG, Hull MW, Gustafson R, Sandhu J, Champagne S, Wong T, Nematallah A, Forsting S, Daly P. 2008. Large community outbreak of Streptococcus pneumoniae serotype 5 invasive infection in an impoverished, urban population. Clin. Infect. Dis. 47:768-774.
14. Tyrrell GJ, Lovgren M, Ibrahim Q, Garg S, Chui L, Boone TJ, Mangan C, Patrick DM, Hoang L, Horsman GB, Van Caeseele P, Marrie TJ. 2012. Epidemic of invasive pneumococcal disease, western Canada, 2005- 2009. Emerg. Infect. Dis. 18:733-740.
15. Martin M, Turco JH, Zegans ME, Facklam RR, Sodha S, Elliott JA, Pryor JH, Beall B, Erdman DD, Baumgartner YY, Sanchez PA, Schwartzman JD, Montero J, Schuchat A, Whitney CG. 2003. An outbreak of conjunctivitis due to atypical Streptococcus pneumoniae. N. Engl. J. Med. 348:1112-1121.
16. Berrón S, Fenoll A, Ortega M, Arellano N, Casal J. 2005. Analysis of the genetic structure of nontypeable pneumococcal strains isolated from conjunctiva. J. Clin. Microbiol. 43:1694-1698.
17. Fenoll A, Granizo JJ, Aguilar L, Giménez MJ, Aragoneses-Fenoll L, Hanquet G, Casal J, Tarragó D. 2009. Temporal trends of invasive Streptococcus pneumoniae serotypes and antimicrobial resistance patterns in Spain from 1979 to 2007. J. Clin. Microbiol. 47:1012-1020.
18. Fenoll A, Jado I, Vicioso D, Pérez A, Casal J. 1998. Evolution of Streptococcus pneumoniae serotypes and antibiotic resistance in Spain: update (1990 to 1996). J. Clin. Microbiol. 36:3447-3454.
19. Klugman KP, Madhi SA, Adegbola RA, Cutts F, Greenwood B, Hausdorff WP. 2011. Timing of serotype 1 pneumococcal disease suggests the need for evaluation of a booster dose. Vaccine 29:3372-3373.
20. Clinical and Laboratory Standards Institute. 2009. Methods for dilution antimicrobial susceptibility test for bacteria that growth aerobically, vol 29, 8th ed. Approved standard M7-A8. Clinical and Laboratory Standards Institute, Wayne, PA.
21. Clinical and Laboratory Standards Institute. 2010. Performance standards for antimicrobial susceptibility testing; 20th informational supplement. CLSI M100-S20. Clinical and Laboratory Standards Institute, Wayne, PA.
22. McGee L, McDougal L, Zhou J, Spratt BG, Tenover FC, George R, Hakenbeck R, Hryniewicz W, Lefvre JC, Tomasz A, Klugman KP. 2001. Nomenclature of major antimicrobial-resistant clones of Streptococcus pneumoniae defined by the pneumococcal molecular epidemiology network. J. Clin. Microbiol. 39:2565-2571.
23. Enright MC, Spratt BG. 1998. A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease. Microbiology 144(Pt 11):3049-3060.
24. Liñares J, Ardanuy C, Pallares R, Fenoll A. 2010. Changes in antimicrobial resistance, serotypes and genotypes in Streptococcus pneumoniae over a 30-year period. Clin. Microbiol. Infect. 16:402-410.
25. Porat N, Benisty R, Trefler R, Givon-Lavi N, Dagan R. 2012. Clonal distribution of common pneumococcal serotypes not included in the 7-valent conjugate vaccine (PCV7): marked differences between two ethnic populations in southern Israel. J. Clin. Microbiol. 50:3472-3477.
26. Tamayo M, Sá-Leão R, Santos Sanches I, Castañeda E, de Lencastre H. 1999. Dissemination of a chloramphenicol- and tetracycline- resistant but penicillin-susceptible invasive clone of serotype 5 Streptococcus pneumoniae in Colombia. J. Clin. Microbiol. 37:2337-2342.
27. Grau I, Ardanuy C, Calatayud L, Rolo D, Domenech A, Liñares J, Pallares R. 2012. Invasive pneumococcal disease in healthy adults: increase of empyema associated with the clonal-type Sweden(1)-ST306. PLoS One 7:e42595. doi:10.1371/journal.pone.0042595.
28. Serrano I, Melo-Cristino J, Carriço JA, Ramirez M. 2005. Characterization of the genetic lineages responsible for pneumococcal invasive disease in Portugal. J. Clin. Microbiol. 43:1706-1715.
29. Obando I, Muñoz-Almagro C, Arroyo LA, Tarrago D, Sanchez-Tatay D, Moreno-Perez D, Dhillon SS, Esteva C, Hernandez-Bou S, Garcia- Garcia JJ, Hausdorff WP, Brueggemann AB. 2008. Pediatric parapneumonic empyema, Spain. Emerg. Infect. Dis. 14:1390-1397.
30. Picazo J, Ruiz-Contreras J, Casado-Flores J, Giangaspro E, Del Castillo F, Hernández-Sampelayo T, Otheo E, Balboa F, RÍos E, Méndez C, Heracles Study Group. 2011. Relationship between serotypes, age, and clinical presentation of invasive pneumococcal disease in Madrid, Spain, after introduction of the 7-valent pneumococcal conjugate vaccine into the vaccination calendar. Clin. Vaccine Immunol. 18:89-94.
31. Sleeman KL, Griffiths D, Shackley F, Diggle L, Gupta S, Maiden MC, Moxon ER, Crook DW, Peto TE. 2006. Capsular serotype-specific attack rates and duration of carriage of Streptococcus pneumoniae in a population of children. J. Infect. Dis. 194:682-688